In a new study published in Nature, Dan Barouch, MD, PhD, Director of BIDMC’s Center for Virology and Vaccine Research, and colleagues report on the antibody and cellular immune responses generated by the Ad26.COV2.S vaccine against the original viral strain and against SARS-CoV-2 variants of concern. The team found that this vaccine induced immune responses against all the viral variants.
A leading COVID-19 vaccine candidate developed at Beth Israel Deaconess Medical Center creates the groundwork for a newly launched COVID-19 vaccine clinical trial
A new study led by researchers at Beth Israel Deaconess Medical Center reveals that while critical care outcomes in ICUs steadily improved over a decade at hospitals with few minority patients, ICUs with a more diverse patient population did not progress comparably.
Both obesity and smoking can have negative effects on bone health. A recent study led by a team at Beth Israel Deaconess Medical Center (BIDMC) examined whether they also impact healing in patients who have undergone surgery for fractures of the wrist, or the distal radius, which are among the most common bone fractures.
Beth Israel Deaconess Medical Center (BIDMC); the Harvard FXB Center for Health and Human Rights; and the Center for Climate, Health, and the Global Environment at the Harvard T.H. Chan School of Public Health (Harvard C-CHANGE), have launched a first-of-its-kind Climate and Human Health Fellowship.